Added: Miquel Nemeth - Date: 05.11.2021 21:17 - Views: 41651 - Clicks: 8214
Study record managers: refer to the Data Element Definitions if submitting registration or information. Talk with your doctor and family members or friends about deciding to a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below.
For general information, Learn About Clinical Studies. Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or information. Search for terms. Save this study. Warning You have reached the maximum of saved studies Listing a study does not mean it has been evaluated by the U. Federal Government. Read our disclaimer for details. Last Update Posted : March 3, Study Description. Sickle cell maculopathy was sparingly mentioned in the literature before despite the fact that sickle cell disease or sickle cell trait is common in people of many areas of the world.
This study shows that OCTA is a very valuable, non invasive, office procedure that may well be used in diagnosing this disease. Detailed Description:. I used OCTA to show macular vascular occlusions that usually happen with this disease. Outcome Measures. Eligibility Criteria. Information from the National Library of Medicine Choosing to participate in a study is an important personal decision.
Inclusion Criteria: people with sickle cell trait or sickle cell disease - Exclusion Criteria: -. Contacts and Locations. Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials. More Information. Layout table for additonal information Responsible Party: Dr. Shawkat Michel, Principal Investigator, Dr. Michel Clinic ClinicalTrials. National Library of Medicine U. National Institutes of Health U. Department of Health and Human Services. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Sickle Cell Retinopathy. Device: Optical Coherence Tomography Angiography. Study Type :. Actual Enrollment :.
Actual Study Start Date :. Actual Primary Completion Date :. Actual Study Completion Date :. Michel Clinic. Optical Coherence Tomography. March 3, Key Record Dates. Retinal Diseases Eye Diseases.Adult dating Octa
email: [email protected] - phone:(339) 548-2033 x 7441
OCTA: More Pinoys ready for Covid jabs